Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure

Neuropharmacology

Volumn 74, Issue , 2013, Pages 119-125

  Sean, McKay ^a   Bengtson, C Peter ^b   Bading, Hilmar ^b   Wyllie, David J A ^a   Hardingham, Giles E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Excitotoxicity; Extrasynaptic; Glutamate receptor; Magnesium; MK 801; NMDA receptor; Pharmacology; Synapse

Indexed keywords

DIZOCILPINE; MAGNESIUM ION; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; BRAIN NERVE CELL; CELL DEATH; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EXCITOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE;

EXCITOTOXICITY; EXTRASYNAPTIC; GLUTAMATE RECEPTOR; MAGNESIUM; MK-801; NMDA RECEPTOR; PHARMACOLOGY; SYNAPSE;

ANIMALS; CATIONS; CELLS, CULTURED; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MAGNESIUM; MEMANTINE; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NERVE DEGENERATION; NEURONS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 84885179724     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.01.024     Document Type: Article

References (36)

1. Al-Mubarak, B., Soriano, F.X., Hardingham, G.E., 2009. Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene. Channels (Austin) 3, 233-238.
2. Bading, H., Ginty, D.D., Greenberg, M.E., 1993. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260, 181-186.
3. Bengtson, C.P., Dick, O., Bading, H., 2008. A quantitative method to assess extrasynaptic NMDA receptor function in the protective effect of synaptic activity against neurotoxicity. BMC Neurosci. 9, 11.
4. Berman, F.W., Murray, T.F., 1996. Characterization of [3H]MK-801 binding to N-methyl-D-aspartate receptors in cultured rat cerebellar granule neurons and involvement in glutamate-mediated toxicity. J. Biochem. Toxicol. 11, 217-226.
5. Bordji, K., Becerril-Ortega, J., Nicole, O., Buisson, A., 2010. Activation of extra-synaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ss production. J. Neurosci. 30, 15927-15942.
6. Chen, H.S., Lipton, S.A., 1997. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. 499 (Pt 1), 27-46.
7. Dick, O., Bading, H., 2010. Synaptic activity and nuclear calcium signaling protects hippocampal neurons from death signal-associated nuclear translocation of FoxO3 a induced by extrasynaptic NMDA receptors. J. Biol. Chem. 285, 19354-19361.
8. Hardingham, G.E., Bading, H., 2002. Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated. Biochim. Biophys. Acta 1600, 148-153.
9. Hardingham, G.E., Bading, H., 2010. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696.
10. Hardingham, G.E., Fukunaga, Y., Bading, H., 2002. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405-414.
11. Harris, A.Z., Pettit, D.L., 2007. Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices. J. Physiol. 584, 509-519.
12. Hubbard, C.M., Redpath, G.T., Macdonald, T.L., VandenBerg, S.R., 1989. Modulatory effects of aluminum, calcium, lithium, magnesium, and zinc ions on [3H]MK-801 binding in human cerebral cortex. Brain Res. 486, 170-174.
13. Huettner, J.E., Bean, B.P., 1988. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natl. Acad. Sci. U. S. A. 85, 1307-1311.
14. Ivanov, A., Pellegrino, C., Rama, S., Dumalska, I., Salyha, Y., Ben-Ari, Y., Medina, I., 2006. Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the ERK activity in cultured rat hippocampal neurons. J. Physiol. 572 (3), 789-798.
15. Le Meur, K., Galante, M., Angulo, M.C., Audinat, E., 2007. Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus. J. Physiol. 580, 373-383.
16. Leveille, F., El Gaamouch, F., Gouix, E., Lecocq, M., Lobner, D., Nicole, O., Buisson, A., 2008. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. Faseb J. 22, 4258-4271.
17. Martel, M., Wyllie, D.J., Hardingham, G.E., 2009. In developing hippocampal neurons, NR2B-containing NMDA receptors can mediate signalling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 158, 334-343.
18. Martel, M.A., Ryan, T.J., Bell, K.F., Fowler, J.H., McMahon, A., Al-Mubarak, B., Komiyama, N.H., Horsburgh, K., Kind, P.C., Grant, S.G., Wyllie, D.J., Hardingham, G.E., 2012. The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults. Neuron 74, 543-556.
19. Milnerwood, A., Gladding, C., Pouladi, M., Kaufman, A., Hines, R., Boyd, J., Ko, R., Vasuta, O., Graham, R., Hayden, M., Murphy, T., Raymond, L., 2010. Early increase in extrasynaptic NMDA receptor signalling and expression contributes to phenotype onset in Huntington's disease mice. Neuron 65, 178-190.
20. Nakayama, K., Kiyosue, K., Taguchi, T., 2005. Diminished neuronal activity increases neuron-neuron connectivity underlying silent synapse formation and the rapid conversion of silent to functional synapses. J. Neurosci. 25, 4040-4051.
21. Okamoto, S., Pouladi, M.A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D.E., Zaidi, R., Clemente, A., Kaul, M., Graham, R.K., Zhang, D., Vincent Chen, H.S., Tong, G., Hayden, M.R., Lipton, S.A., 2009. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med. 15, 1407-1413.
22. Papadia, S., Soriano, F.X., Leveille, F., Martel, M.A., Dakin, K.A., Hansen, H.H., Kaindl, A., Sifringer, M., Fowler, J., Stefovska, V., McKenzie, G., Craigon, M., Corriveau, R., Ghazal, P., Horsburgh, K., Yankner, B.A., Wyllie, D.J., Ikonomidou, C., Hardingham, G.E., 2008. Synaptic NMDA receptor activity boosts intrinsic anti-oxidant defenses. Nat. Neurosci. 11, 476-487.
23. 2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J. Neurosci. 25, 4279-4287.
24. Parsons, C.G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., Danysz, W., 1995. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34, 1239-1258.
25. Puddifoot, C., Martel, M.A., Soriano, F.X., Camacho, A., Vidal-Puig, A., Wyllie, D.J., Hardingham, G.E., 2012. PGC-1alpha negatively regulates extrasynaptic NMDAR activity and excitotoxicity. J. Neurosci. 32, 6995-7000.
26. Reynolds, I.J., Miller, R.J., 1988. Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol. Pharmacol. 33, 581-584.
27. Soriano, F.X., Baxter, P., Murray, L.M., Sporn, M.B., Gillingwater, T.H., Hardingham, G.E., 2009. Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin. Mol. Cells 27, 279-282.
28. Soriano, F.X., Papadia, S., Hofmann, F., Hardingham, N.R., Bading, H., Hardingham, G.E., 2006. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J. Neurosci. 26, 4509-4518.
29. Tovar, K.R., Westbrook, G.L., 1999. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19, 4180-4188.
30. Tovar, K.R., Westbrook, G.L., 2002. Mobile NMDA receptors at hippocampal synapses. Neuron 34, 255-264.
31. Tu, W., Xu, X., Peng, L., Zhong, X., Zhang, W., Soundarapandian, M.M., Balel, C., Wang, M., Jia, N., Zhang, W., Lew, F., Chan, S.L., Chen, Y., Lu, Y., 2010. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140, 222-234.
32. Wahl, A.S., Buchthal, B., Rode, F., Bomholt, S.F., Freitag, H.E., Hardingham, G.E., Ronn, L.C., Bading, H., 2009. Hypoxic/ischemic conditions induce expression of the putative pro-death gene Clca1 via activation of extrasynaptic N-methyl-D-aspartate receptors. Neuroscience 158, 344-352.
33. Wong, E.H., Kemp, J.A., Priestley, T., Knight, A.R., Woodruff, G.N., Iversen, L.L., 1986. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U. S. A. 83, 7104-7108.
34. Wroge, C.M., Hogins, J., Eisenman, L., Mennerick, S., 2012. Synaptic NMDA receptors mediate hypoxic excitotoxic death. J. Neurosci. 32, 6732-6742.
35. 2+in cultured mouse hippocampal neurons. Brain Res. 517, 51-56.
36. Zhang, S.J., Steijaert, M.N., Lau, D., Schutz, G., Delucinge-Vivier, C., Descombes, P., Bading, H., 2007. Decoding NMDA receptor Signaling: identification of genomic programs specifying neuronal survival and death. Neuron 53, 549-562.